Immuron IMRN
NASDAQ IMRN
$1.12 -0.06 (-5.08%)
As of: Aug 21, 2026 · 3:58 PM EDT

Immuron (IMRN) Income towards Parent Company (2016 - 2024)

Immuron (IMRN) posted quarterly Income towards Parent Company of -$1.6 million for Q4 2024, up 21.49% year-over-year from -$1.3 million in Q1 2024, and up 21.49% quarter-over-quarter from -$2.1 million in Q4 2023.

Immuron (IMRN) Income towards Parent Company (2016 - 2024) Analysis & Trends

Immuron's Income towards Parent Company history runs 9 years deep, the most recent figure standing at -$1.6 million for Q4 2024.

  • In Q4 2024, Income towards Parent Company rose 21.49% year-over-year to -$1.6 million; the TTM figure through Sep 2025 stood at -$1.6 million (up 21.49% YoY), while the FY2025 annual figure was -$3.4 million, up 25.67% from the prior year.
  • Income towards Parent Company for Q4 2024 stood at -$1.6 million, up from -$2.1 million in the prior quarter.
  • The five-year high for Income towards Parent Company was -$13260.2 in Q4 2021, with the low at -$2.1 million in Q4 2023.
  • The 5-year median for Income towards Parent Company is -$795595.5 (2022), against an average of -$893766.8.
  • The sharpest annual moves came in 2021 and 2022: Income towards Parent Company jumped 76.89% in 2021, then slumped 2558.11% in 2022.
  • Immuron's Income towards Parent Company stood at -$57387.7 in 2020, then surged by 76.89% to -$13260.2 in 2021, then plunged by 2558.11% to -$352470.5 in 2022, then tumbled by 488.19% to -$2.1 million in 2023, then gained by 21.49% to -$1.6 million in 2024.
  • Business Quant data shows IMRN's Income towards Parent Company at -$1.6 million in Q4 2024, -$2.1 million in Q4 2023, and -$1.2 million in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Immuron 6.75 Mn 6.73 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1.63 Mn
Dec 31, 2023 -2.07 Mn
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 -352,470.52
Dec 31, 2021 -13,260.17
Dec 31, 2020 -57,387.72
Dec 31, 2019 -15,212.27
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 -1.45 Mn
Dec 31, 2016 -2.60 Mn
Jun 30, 2016 -3.28 Mn